[The use of antioxidants in combination therapy of chronic prostatitis].
V Kuzmenko AA Gyaurgiev TV Kuzmenko VA Kuzmenko GPublished in: Urologiia (Moscow, Russia : 1999) (2024)
Currently, the significance of the chronic prostatitis (CP) is undoubted. Oxidative stress is considered as one of the standard mechanisms of cellular damage that is associated with inflammatory diseases such as CP. When choosing the combination therapy for this group of patients, a correction of oxidative stress is pathogenetically justified. Literature data about the pathogenetic feasibility and prospects of using a biologically active complex containing flavonoids and carotenoids quercetin, lycopene and naringin as part of the combination treatment of patients with CP are presented in the article. Considering the various effects of the biologically active complex Querceprost, containing quercetin, lycopene and naringin, among which antioxidant, anti-inflammatory, antimicrobial and immunomodulatory are of greatest importance, as well as taking into account the synergistic effect of flavonoids and carotenoids, we suggest that Querceprost is promising component of combination treatment of patients with CP.
Keyphrases
- oxidative stress
- combination therapy
- anti inflammatory
- end stage renal disease
- ejection fraction
- newly diagnosed
- systematic review
- chronic kidney disease
- ischemia reperfusion injury
- diabetic rats
- peritoneal dialysis
- big data
- electronic health record
- current status
- cancer therapy
- machine learning
- signaling pathway
- patient reported
- data analysis